TITLE

Cyberkinetics, NeuroMetrix in j-v; Ventana opens books

PUB. DATE
November 2007
SOURCE
Medical Technology & Devices Week;11/19/2007, Vol. 5 Issue 46, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This article focuses on the joint venture formed between Cyberkinetics Neurotechnology Systems and NeuroMetrix to accelerate development of therapies for peripheral nerve damage based on Cyberkinetics' Andara oscillating field stimulator therapy platform. Cyberkinetics develops implantable products to treat neurological diseases and injuries. NeuroMetrix develops neurological diagnostic and therapeutic products.
ACCESSION #
27566664

 

Related Articles

  • Cyberkinetics, NeuroMetrix in j-v for peripheral nerve damage.  // Biomedical Business & Technology;Dec2007, Vol. 30 Issue 12, p27 

    This section offers news briefs about the medical instruments sector. A joint venture was formed between Cyberkinetics Neurotechnology Systems and NeuroMetrix to accelerate development of therapies for peripheral nerve damage. ConcepTX Medical has closed a convertible preferred stock financing...

  • Cyberkinetics in j-v with NeuroMetrix for spinal device. Yoffee, Lynn // Biomedical Business & Technology;Mar2008, Vol. 31 Issue 3, p23 

    The article reports on the establishment of peripheral nerve injury repair (PNIR), a joint venture of Cyberkinetics Neurotechnology Systems with NeuroMetrix. The companies will develop and commercialize Andara Oscillating Field Stimulator (OFS) System for a variety of peripheral nerve injury...

  • Cyberkinetics, NeuroMetrix form j-v to develop new nerve injury device. Yoffee, Lynn // Medical Device Daily;2/20/2008, Vol. 12 Issue 34, p1 

    The article reports on the joint venture of Cyberkinetics Neurotechnology Systems with NeuroMetrix for the formation of the peripheral nerve injury repair (PNIR). They will develop and commercialize the Andard Oscillating Field Stimulator (OFS) for different peripheral nerve injury indications....

  • Cyberkinetics, NeuroMetrix in pact for spinal cord device.  // Medical Technology & Devices Week;2/25/2008, Vol. 6 Issue 8, p4 

    The article reports on a joint venture formed between Cyberkinetics Neurotechnology Systems and NeuroMetrix to produce a peripheral nerve injury repair (PNI) device. Cyberkinetics is still waiting for a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for its...

  • Cyberkinetics, NeuroMetrix in j-v; Ventana opens books to Roche. Johnson, Holland // Medical Device Daily;11/15/2007, Vol. 11 Issue 220, p1 

    The article reports on a joint venture between Cyberkinetics Neurotechnology Systems, a developer of implantable products to treat neurological diseases and injuries, and NeuroMetrix, a developer of neurological diagnostic and therapeutic products. The joint venture was said to have been formed...

  • Cyberkinetics Gives Update on BrainGate Clinical Trial.  // O&P Business News;5/15/2005, Vol. 14 Issue 10, p72 

    Reports on interim results of the pilot study of the BrainGateâ„¢ Neural Interface System from Cyberkinetics Neurotechnology Systems Inc. Primary goals of the pilot clinical study; Features of the BrainGate Neural Interface System brain-computer interface; Implications for the treatment of...

  • PRODUCT BRIEFS.  // Medical Device Daily;12/13/2007, Vol. 11 Issue 226, p10 

    This section offers news briefs on the U.S. medical instruments industry. A letter was received by Cyberkinetics Neurotechnology Systems from the Food and Drug Administration (FDA) requesting additional analyses and data for its Humanitarian Device Exemption marketing application for the Andara...

  • Cyberkinetics, NeuroMetrix in j-v; Ventana opens books to Roche. Johnson, Holland // Diagnostics & Imaging Week;11/21/2007, Vol. 10 Issue 47, p3 

    The article presents an update on the diagnostics and imaging technology industry in the U.S. Cyberkinetics Neurotechnology Systems in Foxborough, Massachusetts, and NeuroMetrix in Waltham, have formed a joint venture to accelerate development of therapies for peripheral nerve damage based on...

  • Avacta buys TheraGenetics; Cyberkinetics in assets sale.  // Medical Device Daily;1/30/2009, Vol. 13 Issue 19, p3 

    This section offers news briefs on acquisition deals in the medical device industry as of January 30, 2009. Personalized medicine diagnostics company TheraGenetics was acquired by the Avacta Group, developer of detection and analysis technology geared toward the pharmaceutical and healthcare...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics